AMGN-0007 Uses, Dosage, Side Effects and more
Recombinant osteoprotegerin (AMGN-0007) is a recombinant OPG construct developed as a potential therapeutic agent in the treatment of bone disease.
| Trade Name | AMGN-0007 |
| Generic | AMGN-0007 |
| AMGN-0007 Other Names | Osteoclastogenesis inhibitory factor, Osteoprotegerin recombinant, rOPG |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
Investigated for use/treatment in osteoporosis and bone metastases.
